Picture of Tenax Therapeutics logo

TENX — Tenax Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Tenax Therapeutics Q3 Net Income USD -15.804 Million

Nov 12 (Reuters) - Tenax Therapeutics Q3 operating expenses USD 16.806 million.

Q3 operating income USD -16.806 million

Recent news on Tenax Therapeutics

See all news